Visitor preview: 5 stories per page Create my free account
Events database

GC Biopharma Q3 Operating Profit Jumps 68.5% on Flu Vaccine, Alyglo Sales

Advanced analysis (spheres, detailed sources, paid analyses)
Event date
exact date
Coverage
5 outlets · 5 articles
first · latest
Reporting countries
Portugal, United States
English, Portuguese
Countries concerned
South Korea
Health · intensity 0.0 · tone 0.00
In 5 seconds

Covered mainly by the Western sphere (100%); silent in Sino-Russian & BRICS, Arab-Muslim world, Global South.

Western 100%Sino-Russian & BRICS 0%Arab-Muslim world 0%Global South 0%

Global sphere reading. The left / centre / right reading is shown in the coverage analysis below.

In 30 seconds
  • Confirmed by 4 outlets in 4 countries.
  • Ignored by Sino-Russian & BRICS, Arab-Muslim world, Global South.
  • Propagation: first reported by en.sedaily.com (United States), . No word-for-word republication detected.

Headline clash across the four spheres

Western
Sino-Russian & BRICS

No outlet in this sphere covers the event: blind spot.

Arab-Muslim world

No outlet in this sphere covers the event: blind spot.

Global South

No outlet in this sphere covers the event: blind spot.

Coverage analysis

Analyzing coverage…

Event sources

  1. GC Biopharma Q3 Operating Profit Jumps 68.5% on Flu Vaccine, Alyglo Sales
    en.sedaily.comUnknownUnited States → South KoreaEnglish
  2. South Korea's GC Biopharma Q3 Operating Profit Jumps 68.5% on Alyglo, Flu Vaccine
    finance.biggo.comPTPortugal → South KoreaPortuguese
  3. 韓国のGC Biopharma、7～9月期営業利益68.5％急増――Aligloとインフルワクチンがけん引
    finance.biggo.jpPTJapan → South KoreaJapanese
  4. 韓國GC綠十字Q3營業利益暴增68.5%，Aliglo與流感疫苗領軍
    finance.biggo.com.twPTTaiwan → South KoreaChinese
  5. GC Biopharma Wellbeing Q3 Operating Profit Jumps 39% on Laennec Sales
    en.sedaily.comUnknownUnited States → United StatesEnglish